InvestorsHub Logo
Followers 800
Posts 50868
Boards Moderated 2
Alias Born 12/12/2004

Re: TheFinalCD post# 799

Tuesday, 01/10/2023 9:44:15 AM

Tuesday, January 10, 2023 9:44:15 AM

Post# of 811
Up 85% > FDA phase I trial. > "Vitiligo is a chronic autoimmune depigmenting disorder of the skin, characterized by the loss of pigment producing cells known as melanocytes. Vitiligo is the most common depigmenting skin condition, with a prevalence estimated at 0.5-2% of the world population.1 There is currently only one FDA-approved product for the treatment of vitiligo.

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News